Literature DB >> 24213844

Definition of critical asthma syndromes.

Nicholas Kenyon1, Amir A Zeki, Timothy E Albertson, Samuel Louie.   

Abstract

Urgent visits to the clinic and emergency department for acute severe asthma exacerbations are all too frequent. Existing national guidelines do not present consistent or specific recommendations for the evaluation and treatment of individual asthma patients in respiratory distress. In this vein, we propose the term "critical asthma syndrome" (CAS) to describe any child or adult who is at high risk for fatal asthma. Acute severe asthma, refractory asthma, status asthmaticus, and near-fatal asthma all describe CAS where physical exhaustion from the overwhelming work of breathing leads to respiratory arrest and death from hypoxia or related complications. The authors of this supplement seek to emphasize the importance of early recognition, prompt and coordinated evaluation, and treatment of CAS in the emergency department, hospital, and intensive care units by experienced healthcare provider teams. CAS is not severe persistent asthma where control of symptoms and prevention of exacerbations are targets of chronic disease management in the outpatient setting. The authors address the distinctions between the two entities throughout the supplement, and elaborate on the considerations important in the care of a critically ill patient, including the common errors to avoid. In addition, gaps in knowledge and clinical experience in regards to critical asthma are highlighted. Knowledge gaps include a lack of understanding of how to recognize CAS, how to coordinate and integrate hospital and outpatient resources, when to further phenotype patients with critical asthma in order to facilitate effective treatment, and how to prevent future acute exacerbations. Lastly, CAS is complicated by the fact that asthma care in diverse healthcare settings is haphazard. We recommend that primary care physicians refer patients promptly to an asthma specialist for consultation to reduce the frequency of acute exacerbations and prevent the development of CAS.

Entities:  

Mesh:

Year:  2015        PMID: 24213844      PMCID: PMC6063533          DOI: 10.1007/s12016-013-8395-6

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  27 in total

Review 1.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

2.  The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial.

Authors:  Richard J Martin; Stanley J Szefler; Tonya S King; Monica Kraft; Homer A Boushey; Vernon M Chinchilli; Timothy J Craig; Emily A Dimango; Aaron Deykin; John V Fahy; Elliot Israel; Stephen C Lazarus; Robert F Lemanske; Frank T Leone; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Lisa A Szwejbka; Michael E Wechsler
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

3.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

Review 4.  Asthma diagnosis and treatment: filling in the information gaps.

Authors:  William W Busse
Journal:  J Allergy Clin Immunol       Date:  2011-08-27       Impact factor: 10.793

5.  Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008.

Authors:  Chu-Lin Tsai; Wen-Ya Lee; Nicola A Hanania; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2012-03-03       Impact factor: 10.793

6.  The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines.

Authors:  Anne L Fuhlbrigge; Robert J Adams; Theresa W Guilbert; Evie Grant; Paula Lozano; Susan L Janson; Fernando Martinez; Kevin B Weiss; Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2002-10-15       Impact factor: 21.405

7.  Identification of asthma clusters in two independent Korean adult asthma cohorts.

Authors:  Tae-Bum Kim; An-Soo Jang; Hyouk-Soo Kwon; Jong-Sook Park; Yoon-Seok Chang; Sang-Heon Cho; Byoung Whui Choi; Jung-Won Park; Dong-Ho Nam; Ho-Joo Yoon; Young-Joo Cho; Hee-Bom Moon; You Sook Cho; Choon-Sik Park
Journal:  Eur Respir J       Date:  2012-10-11       Impact factor: 16.671

8.  Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey.

Authors:  Stephen P Peters; Craig A Jones; Tmirah Haselkorn; David R Mink; David J Valacer; Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2007-05-03       Impact factor: 10.793

9.  Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population.

Authors:  Paru Patrawalla; Angeliki Kazeros; Linda Rogers; Yongzhao Shao; Mengling Liu; Maria-Elena Fernandez-Beros; Shulian Shang; Joan Reibman
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

10.  Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1)--California, 2009.

Authors:  Eva Mortensen; Janice Louie; Carol Pertowski; Betsy L Cadwell; Edward Weiss; Meileen Acosta; Bela T Matyas
Journal:  Influenza Other Respir Viruses       Date:  2013-07-15       Impact factor: 4.380

View more
  7 in total

1.  Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository.

Authors:  Steven L Shein; Obada Farhan; Nathan Morris; Nabihah Mahmood; Sherman J Alter; Jocelyn M Biagini Myers; Samantha M Gunkelman; Carolyn M Kercsmar; Gurjit K Khurana Hershey; Lisa J Martin; Karen S McCoy; Jennifer R Ruddy; Kristie R Ross
Journal:  Hosp Pediatr       Date:  2018-01-05

Review 2.  Contemporary treatment of children with critical and near-fatal asthma.

Authors:  Steven L Shein; Richard H Speicher; José Oliva Proença Filho; Benjamin Gaston; Alexandre T Rotta
Journal:  Rev Bras Ter Intensiva       Date:  2016-06

3.  Prognostic nomogram for inpatients with asthma exacerbation.

Authors:  Wakae Hasegawa; Yasuhiro Yamauchi; Hideo Yasunaga; Hideyuki Takeshima; Yukiyo Sakamoto; Taisuke Jo; Yusuke Sasabuchi; Hiroki Matsui; Kiyohide Fushimi; Takahide Nagase
Journal:  BMC Pulm Med       Date:  2017-08-04       Impact factor: 3.317

Review 4.  Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management.

Authors:  Eirini Kostakou; Evangelos Kaniaris; Effrosyni Filiou; Ioannis Vasileiadis; Paraskevi Katsaounou; Eleni Tzortzaki; Nikolaos Koulouris; Antonia Koutsoukou; Nikoletta Rovina
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

Review 5.  The Global Impact of Asthma in Adult Populations.

Authors:  Oladunni Enilari; Sumita Sinha
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

6.  PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia.

Authors:  Jan Beute; Pieter Boermans; Bart Benraad; Jan Telman; Zuzana Diamant; Alex KleinJan
Journal:  Exp Lung Res       Date:  2021-02-05       Impact factor: 2.459

Review 7.  The Evidence for Intravenous Theophylline Levels between 10-20mg/L in Children Suffering an Acute Exacerbation of Asthma: A Systematic Review.

Authors:  Lewis Cooney; Daniel Hawcutt; Ian Sinha
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.